Abstract
Objectives: Numerous patients receive acute migraine care in the Emergency Department (ED) setting. A shift of this care to the outpatient Neurology Clinic and outpatient Infusion Center setting has the potential to optimize clinical management while decreasing resource utilization. Methods: Clinicians and administrators collaborated on the operationalization of an Acute Headache Infusion Clinic run through the outpatient Neurology Clinic. Data was collected on all patients treated in the Acute Headache Infusion Clinic from 9/2018–12/2019. Duration of the outpatient visit, cost per visit, and pre- and post-treatment pain scores were collected. Comparison was made to similar care administered at our institution's Emergency Department. Results: Results from 133 patients were obtained. The outpatient encounter was 3.73 h shorter than the ED encounter and was associated with a cost savings of ~$9400/patient. Patients experienced a substantial decrease in their pain scores with treatment in the outpatient setting. Conclusions: The transition of acute migraine management requiring infusion therapies can successfully be transitioned from the ED to the outpatient setting. This can be associated with shorter clinical encounters with more optimal resource utilization while still providing adequate headache relief. Classification of evidence: This study provides Class III evidence for an outpatient infusion clinic for saving costs and clinical care time for patients with acute migraines requiring infusion therapies.
Original language | English (US) |
---|---|
Article number | 117384 |
Journal | Journal of the Neurological Sciences |
Volume | 423 |
DOIs | |
State | Published - Apr 15 2021 |
Funding
RVL is supported by NIH P50CA221747 , BrainUp grant 2651 . RVL is supported by NCI P50CA221747 SPORE for Translational Approaches to Brain Tumors, BrainUp grant 2136. RVL has received research support from BMS (drug only). RVL is on the speakers' bureau for Novocure. RVL has received honoraria for consulting for Abbvie and Eisai. RVL has received honoraria for serving on advisory board for Monteris. RVL has received honoraria for medical editing for Medlink Neurology and EBSCO Publishing. RVL has received honoraria for developing and presenting CME board review material for American Physician Institute. KC is on the speakers' bureau for Eli Lilly and Company and Allergan. KC has received honoraria for consulting for Eli Lilly and Company. All other authors have no conflicts of interest.
Keywords
- Ambulatory care
- Clinical neurology
- Headache
- Infusion
- Migraine
ASJC Scopus subject areas
- Clinical Neurology
- Neurology